Notice of Establishment, 36338 [E8-14461]

Download as PDF 36338 Federal Register / Vol. 73, No. 124 / Thursday, June 26, 2008 / Notices received within 60-days of the date of this publication. To request more information on the proposed project or to obtain a copy of the information collection plans, please contact Dr. Cathrine Sasek, Coordinator, Science Education Program, Office of Science Policy and Communications, National Institute on Drug Abuse, 6001 Executive Blvd, Room 5237, Bethesda, MD 20892, or call non-toll-free number (301) 443–6071; fax (301) 443–6277; or by e-mail to csasek@nida.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60-days of the date of this publication. FOR FURTHER INFORMATION CONTACT: Dated: June 17, 2008. Mary Affeldt, Associate Director for Management, National Institute on Drug Abuse. [FR Doc. E8–14436 Filed 6–25–08; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health rfrederick on PROD1PC67 with NOTICES Notice of Establishment Pursuant to the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), the Director, National Institutes of Health (NIH), announces the establishment of the Board of Scientific Counselors, National Institute of Biomedical Imaging and Bioengineering (Committee). This Committee shall advise the Director, NIH; the Deputy Director for Intramural Research, NIH; the Director, National Institute of Biomedical Imaging and Bioengineering (NIBIB); and the Scientific Director, NIBIB, concerning the intramural research programs through periodic visits to the laboratories to assess the research in progress, the proposed research, and evaluation of the productivity and performance of tenured, tenure track and staff scientists and physicians. This Committee will consist of eight members, including the Chair, appointed by the Director, NIH, from authorities knowledgeable about biomedical imaging and bioengineering. Duration of this committee is continuing unless formally determined by the Director, NIH, that termination would be in the best public interest. VerDate Aug<31>2005 15:05 Jun 25, 2008 Jkt 214001 Dated: June 18, 2008. Elias A. Zerhouni, Director, National Institutes of Health. [FR Doc. E8–14461 Filed 6–25–08; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4140–01–M National Center for Complementary & Alternative Medicine; Notice of Closed Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Complementary & Alternative Medicine; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel; Clinical Science. Date: July 15, 2008. Time: 2 p.m. to 5 p.m. Agenda: To review and evaluate grant applications; National Institutes of Health. Place: Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Laurie Friedman Donze, PhD, Scientific Review Officer, Office of Scientific Review, National Center for Complementary and Alternative Medicine, NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, 301–402–1030, donzel@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to scheduling conflicts. Dated: June 20, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–14550 Filed 6–25–08; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel; Tools and Technologies to Assess Manual Therapies. Date: July 22, 2008. Time: 11:30 a.m. to 1:30 p.m. Agenda: To review and evaluate grant applications; National Institutes of Health. Place: Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Laurie Friedman Donze, PhD, Scientific Review Officer, Office of Scientific Review, National Center for Complementary and Alternative Medicine, NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, 301–402–1030, donzel@mail.nih.gov. Dated: June 18, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–14555 Filed 6–25–08; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and E:\FR\FM\26JNN1.SGM 26JNN1

Agencies

[Federal Register Volume 73, Number 124 (Thursday, June 26, 2008)]
[Notices]
[Page 36338]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-14461]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Establishment

    Pursuant to the Federal Advisory Committee Act, as amended (5 
U.S.C. Appendix 2), the Director, National Institutes of Health (NIH), 
announces the establishment of the Board of Scientific Counselors, 
National Institute of Biomedical Imaging and Bioengineering 
(Committee).
    This Committee shall advise the Director, NIH; the Deputy Director 
for Intramural Research, NIH; the Director, National Institute of 
Biomedical Imaging and Bioengineering (NIBIB); and the Scientific 
Director, NIBIB, concerning the intramural research programs through 
periodic visits to the laboratories to assess the research in progress, 
the proposed research, and evaluation of the productivity and 
performance of tenured, tenure track and staff scientists and 
physicians.
    This Committee will consist of eight members, including the Chair, 
appointed by the Director, NIH, from authorities knowledgeable about 
biomedical imaging and bioengineering.
    Duration of this committee is continuing unless formally determined 
by the Director, NIH, that termination would be in the best public 
interest.

    Dated: June 18, 2008.
Elias A. Zerhouni,
Director, National Institutes of Health.
[FR Doc. E8-14461 Filed 6-25-08; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.